Skip to main content
Premium Trial:

Request an Annual Quote

HapMap Consortium Gets $3.3M in Additional Cash, Plans to Expand Map

NEW YORK, Feb. 7 (GenomeWeb News) - The International HapMap Consortium has received an additional $3.3 million in public/private support and plans to create an improved version of the map of human genetic variation.


When the mapping project was launched in October 2002, the consortium said it planned to complete a map of common patterns of genetic variation by September 2005. A first draft, with one million markers, is expected to be ready by the end of this month-eight months ahead of schedule.


The consortium said it now plans to build a HapMap roughly five times denser than the map to be produced under the original plan. The new map will use the genotyping capacity of Perlegen Sciences to test an additional 4.6 million single-nucleotide polymorphisms from publicly available databases, the International HapMap Consortium said.


The additional HapMap funding came from the Wellcome Trust, which provided $624,000; Genome Canada/Genome Quebec, which gave $260,000; Bristol-Myers Squibb and Pfizer, which donated $100,000 each; Perlegen Sciences, which is giving at least $1.2 million based on in-kind services; and the National Human Genome Research Institute, which pledged $1 million.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.